Physician profile
Allison Maddock
NPI 1326618984
$8,148.01
in general payments reported to CMS, 2019-2025
23 companies · $1,810 in 2025
The $1,810 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $440 · 2022: $1,269 · 2023: $2,871 · 2024: $1,758 · 2025: $1,810.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,982 · Education: $456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,982.32 |
| Education | $456.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $1,632.31 | 2021-2025 | Opzelura, Opzelura |
| Abbvie INC. | $1,081.33 | 2021-2025 | |
| Arcutis Biotherapeutics, INC. | $916.58 | 2023-2025 | Zoryve |
| Sun Pharmaceutical Industries INC. | $758.39 | 2021-2025 | Winlevi, Ilumya, Absorica Ld |
| E.R. Squibb & Sons, L.L.C. | $613.00 | 2022-2025 | Sotyktu |
| Janssen Biotech, INC. | $550.28 | 2022-2025 | Tremfya |
| Lilly USA, LLC | $409.81 | 2022-2025 | Olumiant, Ebglyss, Taltz |
| Regeneron Healthcare Solutions, INC. | $393.34 | 2021-2025 | Dupixent, Libtayo |
| Novartis Pharmaceuticals Corporation | $302.46 | 2023-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $250.37 | 2023-2025 | Cabtreo, Jublia, Arazlo |
| Genzyme Corporation | $248.21 | 2022-2023 | |
| Amgen INC. | $190.98 | 2022-2025 | Otezla, Otezla |
| Dermavant Sciences, INC. | $176.08 | 2023-2024 | Vtama |
| Janssen Scientific Affairs, LLC | $145.62 | 2022 | |
| Ucb, INC. | $111.29 | 2021-2025 | Bimzelx, Cimzia |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $82.69 | 2025 | Aklief |
| Pfizer INC. | $82.11 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $78.04 | 2023-2024 | Cyltezo, Spevigo |
| Mayne Pharma Commercial LLC | $40.71 | 2022 | |
| Leo Pharma INC. | $34.22 | 2023-2025 | Adbry |
| Organon LLC | $18.08 | 2025 | |
| Verrica Pharmaceuticals INC. | $16.10 | 2024 | Ycanth |
| Krystal Biotech INC | $16.01 | 2025 | Vyjuvek |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Maddock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.